Skip to main content

News & Press Releases

Filter by:

MedTechDive reported that the U.S. Food and Drug Administration is not yet ready to go to Congress to seek new powers for its evolving precertification pilot for software, but it will need new authorities to determine how the experimental path fits into the current regulatory scheme. The article included commentary from Senior Director of ML Strategies Aaron Josephson and Mintz Associate Benjamin Zegarelli.
An article published by Inside Health Policy quoted Aaron Josephson, Senior Director at ML Strategies, extensively in response to recent debate surrounding the U.S. Food and Drug Administration’s proposed rule “Reporting Information Regarding Falsification of Data,” which was previously withdrawn.
The Boston Globe reported that the administration of Governor Charlie Baker has responded to data released by the Massachusetts Department of Transportation confirming that traffic congestion in the state has reached a “tipping point.” In the August 9 article, Senior Vice President of ML Strategies Stephen Silveira said that he supported the Baker administration’s prospective solution of opt-in toll lanes to ease traffic.
On August 12, Senior Vice President of ML Strategies Stephen Silveira was a guest on WBUR, Boston’s NPR News Station to discuss the Massachusetts Department of Transportation’s recent report on traffic congestion, as well as the Massachusetts Bay Transportation Authority’s plans to shut down key sections of the Red, Orange and Green Lines during weekends in the fall.
David O’Connor, Senior Vice President for Energy & Clean Technology at ML Strategies, was recently featured as a guest on an episode of The Lobbying Show, a podcast about the world of lobbying: how it works, who is lobbying, and how to be effective.

Follow ML Strategies